Effect of F2695 on Functional Recovery After Ischemic Stroke

NCT01639014 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

532

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: F2695
DRUG: placebo

Sponsor

Pierre Fabre Medicament